Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes (original) (raw)
Donnelly JJ, Ulmer JB, Liu MA. (1994) Immunization with DNA. J. Immunol. Methods176: 145–152. ArticleCASPubMed Google Scholar
Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. (1997) DNA vaccines. Annu. Rev. Immunol15: 617–648. ArticleCASPubMed Google Scholar
Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ, Gromkwoski SJ, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science259: 1745–1749. ArticleCASPubMed Google Scholar
Ulmer JB, Deck RR, DeWitt CM, Donnelly JJ, Liu MA. (1996) Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells. Immunology89: 59–67. ArticleCASPubMedPubMed Central Google Scholar
Fu T-M, Friedman A, Ulmer JB, Liu MA, Donnelly JJ. (1997) Protective cellular immunity: Cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol.71: 2715–2721. PubMedPubMed CentralCAS Google Scholar
Yewdell JW, Bennink JR. (1992) Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol.52: 1–123. ArticleCASPubMed Google Scholar
Germain RN. (1994) MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell76: 287–299. ArticleCASPubMed Google Scholar
Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL. (1990) Direct gene transfer into mouse muscle in vivo. Science247: 1465–1468. ArticleCASPubMed Google Scholar
Goebels N, Michaelis D, Wekerle H, Hohlfeld R. (1992) Human myoblasts as antigen-presenting cells. J. Immunol.149: 661–667. PubMedCAS Google Scholar
Bevan MJ. (1995) Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med.182: 639–641. ArticleCASPubMed Google Scholar
Montgomery DL, Shiver JW, Keander KR, Perry HC, Friedman A, Martinez D, Ulmer JB, Donnelly JJ, Liu MA. (1993) Heterologous and homologous protection against influenza virus A by DNA vaccination: Optimization of DNA vectors. DNA Cell Biol.12: 777–783. ArticleCASPubMed Google Scholar
Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science264: 961–965. ArticleCASPubMed Google Scholar
Sentman CL, Kumar V, Koo G, Bennet M. (1989) Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts. J. Immunol.142: 1847–1852. PubMedCAS Google Scholar
Zinkernagel RM, Callahan GN, Klein J, Dennert G. (1978) Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus. Nature271: 251–253. ArticleCASPubMed Google Scholar
Sprent J, Lo D, Gao E-K, Ron Y. (1989) T cell selection in the thymus. Immunol. Rev.10: 57–61. Google Scholar
Huang AYC, Bruce AT, Pardoll DM, Levitsky HI. (1996) In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity4: 349–355. ArticleCASPubMed Google Scholar
Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG. (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature351: 290–296. ArticleCASPubMed Google Scholar
Rammensee H-G, Falk K, Rötzschke O. (1993) Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol.11: 213–244. ArticleCASPubMed Google Scholar
Barr E, Leiden JM. (1991) Systemic delivery of recombinant proteins by genetically modified myoblasts. Science254: 1507. ArticleCASPubMed Google Scholar
Guéry J-C, Ria F, Adorini L. (1996) Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J. Exp. Med.183: 751–757. ArticlePubMed Google Scholar
Nair S, Babu JS, Dunham RG, Kanda P, Burke RL, Rouse BT. (1993) Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells. J. Virol.67: 4062–4069. PubMedPubMed CentralCAS Google Scholar
Doe B, Selby M, Barnett S, Baenziger J, Walker CM. (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone-marrow-derived cells. Proc. Natl. Acad. Sci. U.S.A.93: 8578–8583. ArticleCASPubMedPubMed Central Google Scholar
Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr. (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med.2: 1122–1128. ArticleCASPubMed Google Scholar
Corr M, Lee DJ, Carson DA, Tighe H. (1996) Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J. Exp. Med.184: 1555–1560. ArticleCASPubMed Google Scholar
Donnelly JJ, Ulmer JB, Liu MA. (1995) Protective efficacy of intramuscular immunization with naked DNA. In: Liu MA, Hilleman MR, Kurth R (eds). DNA Vaccines: A New Era in Vaccinology. The New York Academy of Sciences, New York, pp. 40–46. Google Scholar
Bevan MJ. (1976) Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol.117: 2233–2238. PubMedCAS Google Scholar
Gooding LR, Edwards CB. (1980) H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J. Immunol.124: 1258–1262. PubMedCAS Google Scholar